Errol Souza - Bionomics Ex Chairman
| BNOXDelisted Stock | USD 0.25 0.01 4.17% |
Insider
Errol Souza is Ex Chairman of Bionomics Ltd ADR
| Age | 71 |
| Phone | 61 8 8150 7400 |
| Web | https://www.bionomics.com.au |
Bionomics Management Efficiency
The company has return on total asset (ROA) of (0.3958) % which means that it has lost $0.3958 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7844) %, meaning that it created substantial loss on money invested by shareholders. Bionomics' management efficiency ratios could be used to measure how well Bionomics manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| MBA MR | Aerovate Therapeutics | 62 | |
| Leila MD | Pmv Pharmaceuticals | 61 | |
| Jc MD | Adagene | 59 | |
| Timothy Pigot | Aerovate Therapeutics | 53 | |
| LLM JD | Rezolute | 63 | |
| Eric Devroe | Acrivon Therapeutics, Common | 45 | |
| Qinghai Zhao | Adagene | 63 | |
| Joe Flanagan | Accustem Sciences | 49 | |
| Timothy MBA | Aerovate Therapeutics | 62 | |
| Man MBA | Adagene | 47 | |
| Oz CPA | Scisparc | 38 | |
| Kristina Masson | Acrivon Therapeutics, Common | 44 | |
| Michael Alley | AN2 Therapeutics | N/A | |
| Josh Eizen | AN2 Therapeutics | N/A | |
| Crystal Mercado | Acrivon Therapeutics, Common | N/A | |
| Benjamin Dake | Aerovate Therapeutics | 48 | |
| Kenneth Cundy | Anebulo Pharmaceuticals | 65 | |
| Joseph Zakrzewski | AN2 Therapeutics | 62 | |
| Winston MBA | Pmv Pharmaceuticals | 48 | |
| Fangyong Du | Adagene | 54 | |
| Donna Dea | Aerovate Therapeutics | N/A | |
Management Performance
| Return On Equity | -0.78 | ||||
| Return On Asset | -0.4 |
Bionomics ADR Leadership Team
Elected by the shareholders, the Bionomics' board of directors comprises two types of representatives: Bionomics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bionomics. The board's role is to monitor Bionomics' management team and ensure that shareholders' interests are well served. Bionomics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bionomics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Spyridon MD, President CEO | ||
| Elizabeth Doolin, Senior Development | ||
| DCPSA FFPM, Consultant Neuroscience | ||
| Errol Souza, Ex Chairman | ||
| FCA BEC, Financial Controller | ||
| FCIS BCom, Company Secretary | ||
| MD DFAPA, Acting Officer | ||
| Julie Kerner, Senior Operations | ||
| Connor MSc, VP Devel |
Bionomics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bionomics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.78 | ||||
| Return On Asset | -0.4 | ||||
| Operating Margin | 89.10 % | ||||
| Current Valuation | (3.09 M) | ||||
| Shares Outstanding | 19.53 M | ||||
| Shares Owned By Insiders | 33.91 % | ||||
| Shares Owned By Institutions | 16.22 % | ||||
| Number Of Shares Shorted | 400.4 K | ||||
| Price To Book | 0.28 X | ||||
| Price To Sales | 386.72 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bionomics Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Bionomics Stock
If you are still planning to invest in Bionomics ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |